| Experience in Therapeutic Areas/Indication
|
| Pain Control - Osteoarthritis, Rheumatoid Arthritis, Neuropathic Pain, Acute Pain
|
| CNS - Alzheimer, Psychotic Disorder, Depression, Anxiety Disorder
|
| Oncology - AIDS-related Cutaneous Kaposi's Sarcoma
|
| Cardiovascular - Hypertension, Congestive Heart Failure, Affinity Purified
|
| Erectile Dysfunction
|
| Gastrointestinal - antiemetic
|
| Antimicrobials, Antiviral Agents, HIV Infection, Multiple Sclerosis
|
|
|
| Experience in Study Design
|
| Multi-center
|
| Parallel/Crossover
|
| Single/Multiple Dose
|
| Titration
|
| Double Blind/Open-Label/Randomized
|
|
|
| Experience in Clinical Phase/Regulatory Submission
|
| Phase I through IV, with concentrated experience in phase II and III trials
|
Integrated Summary of Safety (ISS), Integrated Summary of Efficacy (ISE) - with
record of two on-time successful NDA filings
|
| Product License Application (PLA)
|
